Home › NDC Lookup › RxCUI directory › RxCUI 998254

Chlorpheniramine maleate 4 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet — RxCUI 998254

Name: Chlorpheniramine maleate 4 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet (RxCUI 998254)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 998254 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI998254

Official nameChlorpheniramine maleate 4 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known aspseudoephedrine HCl 60 MG / chlorpheniramine maleate 4 MG Oral Tablet

FDA products mapped1

Package NDCs mapped1

Reported Medicaid activity (SDUD)3,185 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Chlorpheniramine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It's an antihistamine used to temporarily relieve classic hay fever and allergy symptoms — things like a runny nose, sneezing, itchy or watery eyes, and an itchy throat. It works o...
What is chlorpheniramine actually used for?
Yes — drowsiness is one of the most common effects of chlorpheniramine, and it can be significant. Don't plan on driving or operating heavy machinery until you know how your body r...
It's best to skip the alcohol while you're taking chlorpheniramine. Alcohol makes the drowsiness much stronger, which can be unsafe — especially if you need to drive or stay alert....

📖 Read our full Chlorpheniramine guide →

🕸️ Concept Web — How Chlorpheniramine maleate 4 MG / pseudoephedrine... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Chlorpheniramine maleate 4 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet RxCUI 998254 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Chlorpheniramine 2400 IN
- Pseudoephedrine 8896 IN
- Chlorpheniramine / pseudoephedrine 214395 MIN
- Chlorpheniramine maleate 142429 PIN
- Pseudoephedrine hydrochloride 91168 PIN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Chlorpheniramine / pseudoephedrine Oral Tablet 371439 SCDF
- Chlorpheniramine maleate / pseudoephedrine hydrochloride Oral Tablet 2645584 SCDFP
- Chlorpheniramine / pseudoephedrine Oral Product 1155143 SCDG
- Chlorpheniramine / pseudoephedrine Pill 1155144 SCDG
- Chlorpheniramine maleate / pseudoephedrine hydrochloride Oral Product 2663301 SCDGP
- Chlorpheniramine maleate / pseudoephedrine hydrochloride Pill 2660755 SCDGP
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 2

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Chlorpheniramine maleate 4 MG 998253 SCDC
- Pseudoephedrine hydrochloride 60 MG 996721 SCDC

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Chlorpheniramine maleate 4 MG SCDC · 998253
Pseudoephedrine hydrochloride 60 MG SCDC · 996721
Chlorpheniramine / pseudoephedrine Oral Tablet SCDF · 371439
Chlorpheniramine maleate / pseudoephedrine hydrochloride Oral Tablet SCDFP · 2645584
Chlorpheniramine / pseudoephedrine Oral Product SCDG · 1155143
Chlorpheniramine / pseudoephedrine Pill SCDG · 1155144
Chlorpheniramine maleate / pseudoephedrine hydrochloride Oral Product SCDGP · 2663301
Chlorpheniramine maleate / pseudoephedrine hydrochloride Pill SCDGP · 2660755

📦 FDA Products & Package NDCs

1 product · 1 package NDC

1 package NDC map to RxCUI 998254 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00904-5351-24	1 BLISTER PACK in 1 CARTON (0904-5351-24) / 24 TABLET in 1...	SudoGest	Major Pharmaceuticals	1992-12-16

Observed labelers: Major Pharmaceuticals (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$0.0633

Range $0.0633–$0.0633 · middle 50% $0.0633–$0.0633 · 1 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.